ArticleDiabetes care2026
Progression to Diabetes by Adults With Prediabetes Who Use the National Diabetes Prevention Program: A Natural Experiment.
Article in Diabetes care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The U.S. National Diabetes Prevention Program Demonstrates Effectiveness With Insufficient Reach.Diabetes care · 2026Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
Abstract
objectiveThe U.S. National Diabetes Prevention Program (NDPP) is an intensive lifestyle intervention to prevent type 2 diabetes, but its real-world effectiveness is unclear. We estimated NDPP's effectiveness to prevent diabetes among insured, high-risk adults. RESEARCH DESIGN AND
methodsThis comparative cohort study included privately insured adults enrolled in 5,714 health plans spanning all 50 states who had medical claims between 2015 and 2019 indicating diagnosed prediabetes, followed by at least one procedure code indicating engagement in some form of lifestyle treatment. Each patient was classified as NDPP treated (at least one NDPP claim) or NDPP untreated (at least one claim for lower-intensity services only). In the same quarter when each patient became eligible, we calculated the proportion of others in the same health plan who participated in NDPP. We used this variable, reflecting the intensity of external encouragement to start NDPP, as an instrumental variable (IV) to estimate differences in diabetes progression after NDPP treatment, while adjusting for individual risk factors.
resultsAmong 3.73 million adults with diagnosed prediabetes, 245,896 had at least one claim for lifestyle treatment, of whom 27,703 (11.3%) were NDPP treated. NDPP-treated patients were more often women, aged <55 years, and less likely to live in low-poverty zip codes. With IV estimation, for every 100 adults participating in NDPP rather than in lower-intensity services, there were 1.94 (95% CI 1.44-2.44) and 1.58 (95% CI 0.76-2.39) fewer cases of diabetes at 12 and 24 months, respectively.
conclusionsFor privately insured adults with prediabetes, using NDPP was associated with lower progression to diabetes over 1-2 years.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.